Brevetti EPO No.4007758 2026.05.13
Brevetti EPO
(10) Registration Number and Date
2026000353 2026.08.24
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2026/000353 2020.07.31
(40) Publication Number and Date
SM /T/2026/000353 2026.08.24
(30) Priority Details
US 201962882081 P
2019.08.02
US 201962944643 P
2019.12.06
US 202062982935 P
2020.02.28
(71/73) Applicant
(IT) MERSANA THERAPEUTICS, INC. : 840 Memorial Drive, Cambridge, MA 02139, US
(72) Inventor
(IT) JONES, Brian D. : 161 Kelton St 2, Allston, Massachusetts 02134, US
(IT) BENTLEY, Keith W. : 25 Charlton St, Apt 208, Everett, Massachusetts 02149, US
(IT) KELLEHER, Eugene W. : 20 Sunnyside Avenue, Wellesley, Massachusetts 02482, US
(IT) TOADER, Dorin : 1699 Cambridge Street Apt 32, Cambridge, Massachusetts 02138, US
(IT) DUVALL, Jeremy R. : 27 Paon Blvd, Wakefield, Massachusetts 01880, US
(IT) RAY, Soumya S. : 134 Franklin Avenue, Quincy, Massachusetts 02170, US
(IT) THOMAS, Joshua D. : 83 Bacon Street, Natick, Massachusetts 01760, US
(74) Representative Name
(IT) MONTEBELLI, Marco : Piazza E. Enriquez, 22c, 47891 Dogana RSM, SM
(54) Title
(IT) DERIVATI DI BIS-[N-((5-CARBAMOIL)-1H-BENZO[D]IMIDAZOL-2-IL)-PIRAZOL-5-CARBOSSAMMIDE] E COMPOSTI CORRELATI COME AGONISTI DI STING (STIMOLATORE DEI GENI DELL'INTERFERONE) PER IL TRATTAMENTO DEL CANCRO
(EN) BIS-[N-((5-CARBAMOYL)-1H-BENZO[D]IMIDAZOL-2-YL)-PYRAZOL-5-CARBOXAMIDE] DERIVATIVES AND RELATED COMPOUNDS AS STING (STIMULATOR OF INTERFERON GENES) AGONISTS FOR THE TREATMENT OF CANCER
(57) Abstract
(58) Citations